Literature DB >> 20354774

Probing the effect of transport inhibitors on the conformation of the mitochondrial citrate transport protein via a site-directed spin labeling approach.

June A Mayor1, Jiakang Sun, Rusudan Kotaria, D Eric Walters, Kyoung Joon Oh, Ronald S Kaplan.   

Abstract

The present investigation utilized the site-directed spin labeling method of electron paramagnetic resonance (EPR) spectroscopy to identify the effect of citrate, the natural ligand, and transport inhibitors on the conformation of the yeast mitochondrial citrate transport protein (CTP) reconstituted in liposomal vesicles. Spin label was placed at six different locations within the CTP in order to monitor conformational changes that occurred near each of the transporter's two substrate binding sites, as well as at more distant domains within the CTP architecture. We observed that citrate caused little change in the EPR spectra. In contrast the transport inhibitors 1,2,3-benzenetricarboxylate (BTC), pyridoxal 5'-phosphate (PLP), and compound 792949 resulted in spectral changes that indicated a decrease in the flexibility of the attached spin label at each of the six locations tested. The rank order of the immobilizing effect was compound 792949 > PLP > BTC. The four spin-label locations that report on the CTP substrate binding sites displayed the greatest changes in the EPR spectra upon addition of inhibitor. Furthermore, we found that when compound 792949 was added vectorially (i.e., extra- and/or intra-liposomally), the immobilizing effect was mediated nearly exclusively by external reagent. In contrast, upon addition of PLP vectorially, the effect was mediated to a similar extent from both the external and the internal compartments. In combination our data indicate that: i) citrate binding to the CTP substrate binding sites does not alter side-chain and/or backbone mobility in a global manner and is consistent with our expectation that both in the absence and presence of substrate the CTP displays the flexibility required of a membrane transporter; and ii) binding of each of the transport inhibitors tested locked multiple CTP domains into more rigid conformations, thereby exhibiting long-range inter-domain conformational communication. The differential vectorial effects of compound 792949 and PLP are discussed in the context of the CTP homology-modeled structure and potential mechanistic molecular explanations are given.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354774      PMCID: PMC2867622          DOI: 10.1007/s10863-010-9280-0

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  36 in total

1.  The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion.

Authors:  Jamie W Joseph; Mette V Jensen; Olga Ilkayeva; Ferdinando Palmieri; Cristina Alárcon; Christopher J Rhodes; Christopher B Newgard
Journal:  J Biol Chem       Date:  2006-09-25       Impact factor: 5.157

2.  Identification of the substrate binding sites within the yeast mitochondrial citrate transport protein.

Authors:  Chunlong Ma; Sreevidya Remani; Jiakang Sun; Rusudan Kotaria; June A Mayor; D Eric Walters; Ronald S Kaplan
Journal:  J Biol Chem       Date:  2007-03-30       Impact factor: 5.157

3.  Simulation of nitroxide electron paramagnetic resonance spectra from brownian trajectories and molecular dynamics simulations.

Authors:  Susan C DeSensi; David P Rangel; Albert H Beth; Terry P Lybrand; Eric J Hustedt
Journal:  Biophys J       Date:  2008-01-30       Impact factor: 4.033

Review 4.  Recent advances in site-directed spin labeling of proteins.

Authors:  W L Hubbell; A Gross; R Langen; M A Lietzow
Journal:  Curr Opin Struct Biol       Date:  1998-10       Impact factor: 6.809

5.  The mitochondrial citrate transport protein: evidence for a steric interaction between glutamine 182 and leucine 120 and its relationship to the substrate translocation pathway and identification of other mechanistically essential residues.

Authors:  Chunlong Ma; Sreevidya Remani; Rusudan Kotaria; June A Mayor; D Eric Walters; Ronald S Kaplan
Journal:  Biochim Biophys Acta       Date:  2006-06-29

6.  The yeast mitochondrial citrate transport protein: characterization of transmembrane domain III residue involvement in substrate translocation.

Authors:  Chunlong Ma; Rusudan Kotaria; June A Mayor; Sreevidya Remani; D Eric Walters; Ronald S Kaplan
Journal:  J Biol Chem       Date:  2004-10-21       Impact factor: 5.157

7.  Localization of the human mitochondrial citrate transporter protein gene to chromosome 22Q11 in the DiGeorge syndrome critical region.

Authors:  N Heisterkamp; M P Mulder; A Langeveld; J ten Hoeve; Z Wang; B A Roe; J Groffen
Journal:  Genomics       Date:  1995-09-20       Impact factor: 5.736

8.  Inhibitors of the mitochondrial citrate transport protein: validation of the role of substrate binding residues and discovery of the first purely competitive inhibitor.

Authors:  Sreevidya Aluvila; Jiakang Sun; David H T Harrison; D Eric Walters; Ronald S Kaplan
Journal:  Mol Pharmacol       Date:  2009-10-20       Impact factor: 4.436

Review 9.  Metabolic cycling in control of glucose-stimulated insulin secretion.

Authors:  Mette V Jensen; Jamie W Joseph; Sarah M Ronnebaum; Shawn C Burgess; A Dean Sherry; Christopher B Newgard
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-26       Impact factor: 4.310

10.  The yeast mitochondrial citrate transport protein: identification of the Lysine residues responsible for inhibition mediated by Pyridoxal 5'-phosphate.

Authors:  Sreevidya Remani; Jiakang Sun; Rusudan Kotaria; June A Mayor; June M Brownlee; David H T Harrison; D Eric Walters; Ronald S Kaplan
Journal:  J Bioenerg Biomembr       Date:  2008-11-11       Impact factor: 2.945

View more
  1 in total

1.  The yeast mitochondrial citrate transport protein: molecular determinants of its substrate specificity.

Authors:  Sreevidya Aluvila; Rusudan Kotaria; Jiakang Sun; June A Mayor; D Eric Walters; David H T Harrison; Ronald S Kaplan
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.